BioNTech SE Receivables 2019-2024 | BNTX

BioNTech SE receivables for the quarter ending September 30, 2024 were $1.317B, a 47.18% decline year-over-year.

  • BioNTech SE receivables for 2023 were $2.527B, a 66.44% decline from 2022.
  • BioNTech SE receivables for 2022 were $7.529B, a 48.6% decline from 2021.
  • BioNTech SE receivables for 2021 were $14.649B, a 7608.51% increase from 2020.

BioNTech SE Receivables 2019-2024 | BNTX

  • BioNTech SE receivables for 2023 were $2.527B, a 66.44% decline from 2022.
  • BioNTech SE receivables for 2022 were $7.529B, a 48.6% decline from 2021.
  • BioNTech SE receivables for 2021 were $14.649B, a 7608.51% increase from 2020.